Alex May

Alex May currently serves as the Director of Regulatory Science, Policy, & Intelligence for North America at CSL Behring, a position held since January 2023. Prior to this role, Alex directed the science and regulatory policy portfolio at the Biotechnology Innovation Organization, focusing on areas such as Manufacturing, Quality, Distribution, Pediatrics, and FDA interactions. Additionally, experience includes serving as ICH Coordinator, contributing to international strategy and policy efforts. Alex has also worked as a freelance writer and held various consulting roles at Eagle Hill Consulting, providing FDA strategy and project management support. Educational background consists of a Bachelor of Science in Neuroscience from William & Mary and a Master of Science in Physiology & Biophysics from Virginia Commonwealth University School of Medicine.